Elevator Pitch: Shortening Time-to-Antibiotic...

Currently, there are three treatments currently available for the treatment of pulmonary hypertension, which all work to slow the rate of loss of lung function. However, the treatment landscape is likely to evolve with the positive TETON trials demonstrating that inhaled treprost ...  Show more

Did you know there might be a state chapter of the ATS near you? Host Erika Moseson, MD, MA, Oregon Thoracic Society, talks with Edward Kilb, MD, ATSF, South Carolina Thoracic Society, and W. Dwight Miller, MD, MS, Florida Thoracic Society, about the vital role of ATS state chapt ...  Show more

Dr. Wes Ely from Vanderbilt University School of Medicine joins us on Rounds to discuss the evolution of our understanding and the current impact of ICU-acquired brain disease on our patients and their loved ones. In addition to discussing the evidence behind current best practic ...  Show more

Dr. Zach Deutch interviews the co-editors of April’s ASA Monitor, Dr. Shahla Siddiqui and Dr. Ashish Khanna, about evolving trends, practices, and procedures in critical care medicine. From new guidelines related to perioperative tube feeding to the use of mechanical circulati ...

Welcome back to the podcast!

This month we start off thinking about sepsis, specifically fluid management and whether a restrictive approach to fluid resuscitation in combination with earlier vasopressors is advantageous over a liberal approach.

Next we have a lo ...

There's an innovative, but risky way we could speed up development of a COVID-19 vaccine. Some scientists argue we should intentionally infect volunteers with the coronavirus to get a vaccine sooner. How would it work? Today's special episode is a collaboration with Tradeoffs, a ...  Show more